People: Axcella Health Inc (AXLA.OQ)

AXLA.OQ on NASDAQ Stock Exchange Global Market

2:29am IST
Change (% chg)

$-0.03 (-0.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chardonnet, Laurent 

Mr. Laurent Chardonnet serves as Chief Financial Officer, Senior Vice President, Principal Accounting Officer of the Company. He joins the company following a 15-year tenure at Incyte Corporation during which he helped it grow from a $500 million development-stage organization into a $20 billion commercial biopharmaceutical company. While at Incyte, Mr. Chardonnet served as Vice President, Treasurer and Principal Accounting Officer from 2005 to 2015 as well as the Head of Finance and Administration for the company’s European division from 2015 to 2017. Most recently, as Incyte’s Vice President of Alliances from 2017 to 2019, he aligned the company’s alliances with its overall strategy. Prior to Incyte, Mr. Chardonnet served as Controller, Vice President of Finance and acting Chief Financial Officer of DrugAbuse Sciences, a privately held biotechnology company, and as a senior consultant at PricewaterhouseCoopers. He began his career working within the finance organizations at Guerbet Biomedical and Sanofi-Aventis. Mr. Chardonnet received his Master of Business Administration from Vanderbilt University and his initial business degree from the Institut Superieur de Gestion in Paris.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --